324 related articles for article (PubMed ID: 33578119)
1. Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities.
Srivastava AK; Chand Yadav T; Khera HK; Mishra P; Raghuwanshi N; Pruthi V; Prasad R
J Autoimmun; 2021 Mar; 118():102614. PubMed ID: 33578119
[TBL] [Abstract][Full Text] [Related]
2. Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis.
Shellard EM; Rane SS; Eyre S; Warren RB
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785955
[TBL] [Abstract][Full Text] [Related]
3. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.
Killeen ME; Ferris L; Kupetsky EA; Falo L; Mathers AR
J Immunol; 2013 Apr; 190(8):4324-36. PubMed ID: 23479230
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-23 and the IL-23/T
Girolomoni G; Strohal R; Puig L; Bachelez H; Barker J; Boehncke WH; Prinz JC
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1616-1626. PubMed ID: 28653490
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity in the pathogenesis of psoriasis.
Sweeney CM; Tobin AM; Kirby B
Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
Nakajima K
J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
[TBL] [Abstract][Full Text] [Related]
7. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K; Beikler T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
9. Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies.
Bugaut H; Aractingi S
Front Immunol; 2021; 12():621956. PubMed ID: 33717124
[TBL] [Abstract][Full Text] [Related]
10. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
[TBL] [Abstract][Full Text] [Related]
11. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.
Schäbitz A; Eyerich K; Garzorz-Stark N
J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274
[TBL] [Abstract][Full Text] [Related]
12. The role of Th17 cells in psoriasis.
Li B; Huang L; Lv P; Li X; Liu G; Chen Y; Wang Z; Qian X; Shen Y; Li Y; Fang W
Immunol Res; 2020 Oct; 68(5):296-309. PubMed ID: 32827097
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
[TBL] [Abstract][Full Text] [Related]
14. Current Concepts of Psoriasis Immunopathogenesis.
Vičić M; Kaštelan M; Brajac I; Sotošek V; Massari LP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769005
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.
Woo YR; Cho DH; Park HJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232931
[TBL] [Abstract][Full Text] [Related]
16. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of five single nucleotide polymorphisms related to IL23/Th17 pathway in the risk of psoriasis.
Yin X; Cheng H; Zhang R; Fan X; Zhou F; Jiang L; Tang X; Chen G; Zuo X; Zheng X; Yang S; Zhang X
Immunogenetics; 2014 Mar; 66(3):215-8. PubMed ID: 24419661
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of psoriasis].
Schäkel K; Schön MP; Ghoreschi K
Hautarzt; 2016 Jun; 67(6):422-31. PubMed ID: 27246016
[TBL] [Abstract][Full Text] [Related]
19. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.
Lowes MA; Russell CB; Martin DA; Towne JE; Krueger JG
Trends Immunol; 2013 Apr; 34(4):174-81. PubMed ID: 23291100
[TBL] [Abstract][Full Text] [Related]
20. Cellular sources of IL-17 in psoriasis: a paradigm shift?
Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC
Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
